Hearing

Hearing loss is the largest modifiable midlife risk factor for dementia, tied with high LDL cholesterol, and it travels with worse health and modestly higher death rates. What nobody has proved is that treating it protects the brain: the one randomised trial missed its main goal.

Get your hearing measured, and if you have hearing loss, treat it and wear the device every day — it is worth doing for conversation, work and social life whether or not it protects the brain. Wear filtered earplugs around loud noise, keep personal audio within 80 dB for 40 hours a week, and if you struggle in noisy rooms despite a "normal" test, ask for extended high-frequency audiometry.

Why hearing loss matters beyond hearing

Hearing loss is not just a normal part of ageing. The 2024 Lancet Commission on dementia ranks hearing loss as the largest modifiable risk factor in midlife, tied with high LDL cholesterol: each accounts for an estimated 7% of dementia cases worldwide.[1] It tops the list because it is common, not because it is individually dangerous — a modest 1.4-fold risk, multiplied across a prevalence the Commission puts at 59%.

Hearing loss also goes with dying sooner, though less clearly than the headline suggests, and like the dementia link this rests entirely on observational studies. Pooling 36 cohort studies and 6.4 million people, adults with hearing loss died at about 21% higher rates, with about 22% more cardiovascular deaths and 11% more cancer deaths.[2] The cohorts disagree sharply, though: the pooled figure is carried by Asian and North American studies, and across the five European cohorts the link is flat. Loss measured by a hearing test tracked a stronger signal (about 28%) than self-reported loss (about 13%), but that gap is suggestive, not established.

Much of that may be age and disadvantage in disguise. In a German study of 8,886 adults aged 35–74, all tested by audiometry, people with hearing loss died at more than five times the crude rate — and at the same rate once age, sex and socioeconomic status were accounted for. Follow-up was short, so one cohort does not overturn the pooled estimate; the authors read hearing loss as an early marker of vascular trouble rather than an independent predictor of death.[3]

That vascular link is the usual explanation for why hearing loss travels with diabetes and heart disease. The cochlea's dense capillary bed, the stria vascularis, needs constant blood flow to power the hair cells, and disrupted flow, low oxygen and inflammation there are among the better-understood causes of age-related hearing loss.[4]

Do hearing aids protect the brain? Possibly, but the trial missed

Hearing aids that are worn and actually help probably lower dementia risk somewhat, but that is not proven. The only randomised trial missed its main goal: a hearing intervention did not slow 3-year cognitive decline in 977 older adults compared with health education. In its 238 higher-risk participants, drawn from a long-running heart study, decline was about 48% slower, but that is a subgroup of a null trial: a reason to keep testing, not proof.[5]

Observational evidence points the same way. An analysis of 2,777 Australians aged 70 and over with self-reported hearing problems, built to mimic a trial but not one, found 7-year dementia risk of 5.0% with hearing aids against 7.5% without — about 2.5 fewer diagnoses per 100 people. The authors cannot rule out confounding, a correction to the paper was published in April 2026, and the difference showed up in dementia diagnoses rather than in cognitive test scores.[6] Pooled across 46 studies and 231,565 people, hearing-aid use goes with about 16% lower risk of cognitive impairment.[7]

Use matters more than purchase. Across seven cohorts and 61,089 adults with hearing loss, lower dementia risk appeared only in people who said the aid actually improved their hearing (about 14% lower), and vanished in those who said it did not.[8] The same holds for death: among 1,863 US adults with measured hearing loss, followed about 10 years, regular users died at about three-quarters the rate of never-users and occasional users showed no benefit — though healthier people may simply be likelier to wear aids.[9]

How hearing loss might drive dementia is unknown. Three ideas lead:

  • Strain. Decoding a degraded signal uses up mental resources needed for everything else.
  • Brain shrinkage. In one long-running US ageing study, people with hearing loss lost temporal-lobe and whole-brain volume faster,[10] and poorer hearing at a mean age of 54 predicted steeper hippocampal decline nearly two decades later.[11] Both are observational and from the same cohort.
  • Isolation. Hearing loss drives social withdrawal, which the Lancet model counts as a dementia risk factor in its own right. In ACHIEVE, the hearing intervention reduced loneliness and slowed the loss of social contacts, by about one person, as exploratory outcomes.[12] See Purpose.

None is established. Measurement error, shared causes, reverse causation and selection bias could each produce the link on their own,[13] and a genetic study found no causal path from hearing loss to Alzheimer's disease specifically, though the links it did find ran through loneliness, low mood and medial temporal lobe volume.[14] A 2025 review reached the same verdict: the evidence for a direct causal link is not conclusive, and some genetic studies suggest hearing loss may be an early feature of Alzheimer's disease rather than a cause of it.[15]

Getting tested: a normal audiogram can miss the problem

The standard screen averages four pitches from 0.5 to 4 kHz, and the standard audiogram stops at 8 kHz, missing damage higher up that may matter for the commonest complaint: not following conversation in a noisy restaurant.

Extended high-frequency audiometry tests above that ceiling, and the evidence that it explains more is thin. In a Swedish group of 263 adults, the standard average explained roughly 19–25% of differences in speech-in-noise scores, and thresholds at 10–16 kHz about 34–36%.[16] An apparent advantage, but two-thirds of the variation is explained by neither, and the study is a single-author, cross-sectional preprint not yet peer-reviewed. Whether "hidden hearing loss" from lost nerve synapses also plays a part is contested in both directions.

The main US guideline, from the American Academy of Otolaryngology–Head and Neck Surgery Foundation, covers adults aged 50 and over and grades its statements differently.[17] Its core:

  • Screen for hearing loss at healthcare visits from 50 — a recommendation, with no consensus on how often.
  • Look in the ear for wax or infection, then get a full audiogram (a strong recommendation) whenever a screen suggests loss.
  • Investigate markedly one-sided loss, conductive or mixed loss, or poor word recognition as something other than ageing.
  • Offer properly fitted hearing aids, and refer for a cochlear-implant assessment if well-fitted aids still leave speech hard to understand (both strong).
  • Retest at least every 3 years if you have known hearing loss or a new concern (an option, the guideline's weakest grade).

It recommends nothing before 50 and does not mention extended high-frequency testing, so expect to ask for it. The US Preventive Services Task Force finds the evidence insufficient to judge screening adults over 50 who have noticed nothing — neither for nor against — and its statement excludes anyone with symptoms.[18] If you struggle in restaurants, get tested.

A baseline audiogram in your forties, repeated every 3–5 years, is our suggestion rather than any guideline's: it makes later change measurable instead of a guess.

Diabetes: the hearing loss nobody screens for

In US survey data on 5,140 adults aged 20 to 69, hearing impairment was roughly twice as common in people with diabetes, after accounting for age, noise exposure, ear-damaging medicines and smoking.[19] A 2026 review found about one in four adults with diabetes has moderate-or-worse hearing loss, with roughly 2.4 times the odds of controls. The odds were tripled under 60 and not clearly raised from 60 onwards: an early complication, not a late one. All the studies are observational and they vary widely.[20]

High blood sugar is thought to damage the cochlea's blood supply and the synapse between hair cells and nerve, though that rests heavily on animal work.[21] The link runs both ways: hearing impairment also predicts new diabetes.[22] Prediabetes already carries about a 30% higher rate of hearing loss.[23]

If you have prediabetes, type 2 diabetes or metabolic syndrome, treat new difficulty in noise as a possible early signal rather than normal ageing. No trial has shown that tighter glucose control preserves hearing.

Noise, polluted air and ear-damaging chemicals

It is well established that noise damage follows dose, and the decibel scale is logarithmic, so safe time collapses fast. These are the World Health Organization's weekly allowances and its own example sounds:[24]

Sound levelExampleSafe exposure per week
80 dBDoorbell40 hours
85 dBHeavy traffic, inside a car12 h 30 min
90 dBShouted conversation4 hours
95 dBMotorcycle1 h 15 min
100 dBHair dryer20 minutes

The allowance is weekly, so a loud gym class and a concert draw on the same budget. For personal audio, the 2019 WHO and International Telecommunication Union standard sets 80 dB for 40 hours a week for adults and 75 dB for children.[25] WHO's "more than 1 billion young people at risk" from earbuds and venues[26] is a modelled range of 0.67 to 1.35 billion people exposed to unsafe listening, not people already losing hearing.[27] Its 2022 venue standard, a 100 dB average ceiling, is a recommendation, not law.[28]

Polluted air probably makes noise worse, by an uncertain amount. In 1,179 Chinese oil workers, high cumulative noise alone more than doubled the risk of work-related hearing loss, and poor air quality added about 8% on top in the main analysis. The nearly six-fold figure usually quoted comes from a later regrouping of the data and is exploratory: in the same cohort, coarse dust ran the other way and other pollutants followed curved, inconsistent patterns.[29] For tinnitus, a UK Biobank analysis of 79,277 people found only a weak link with pollution, about 3% higher odds after full adjustment.[30] Where you can, avoid combining loud noise with polluted air, as on airport runways, in heavy traffic or in refinery work. See Environmental toxins.

Chemicals are a third route that earplugs cannot block. A review of 62 substances found strong evidence of ear damage for only 26.[31] The US National Institute for Occupational Safety and Health estimates that about 22 million US workers are exposed to ear-damaging chemicals each year, about 12 million alongside loud noise; many are breathed in, swallowed or absorbed through the skin.[32]

GroupExamples and where you meet them
SolventsToluene, styrene, xylene, trichloroethylene — paints, adhesives, degreasers, refinishing
Heavy metalsLead, mercury, organic tin — old paint and plumbing, contaminated water and fish, antifouling paints; cadmium, arsenic and manganese suspected
AsphyxiantsCarbon monoxide, hydrogen cyanide, tobacco smoke — engine exhaust in garages, smoking and second-hand smoke
Nitriles and pesticidesPlastics, rubber and acrylic-fibre manufacture; organophosphates in farm and forestry spraying
Aminoglycoside antibioticsGentamicin, streptomycin — monitor closely, especially with kidney disease
Loop diureticsFurosemide — risk adds up with other ear-damaging drugs
Platinum chemotherapyCisplatin, carboplatin — permanent, builds with dose, hearing loss in half or more of patients
PainkillersHigh-dose salicylates cause tinnitus that reverses on stopping. In 55,850 women, more than six years of regular anti-inflammatory or paracetamol use tracked about 10% higher risk of lasting hearing loss; aspirin did not.[33]

For most healthy adults the realistic hazards are solvents without ventilation, carbon monoxide from engines in garages, and several ear-damaging medicines at once. If you take three or more, ask a pharmacist.

What to wear: hearing aids, over-the-counter devices and earplugs

For modern AI hearing aids, the most quoted figure, up to 28% better speech understanding in difficult listening, comes from one manufacturer's launch material, is a ceiling rather than a typical result, and has no independent replication.[34] The independent evidence is more modest and more useful: a Cochrane review of 16 randomised trials in 2,261 adults found a large benefit on listening ability and hearing-related quality of life at moderate certainty, but no shown benefit for working memory.[35]

In the US, adults with perceived mild-to-moderate loss have been able to buy hearing aids over the counter since 17 October 2022, without an exam or professional fitting.[36] Self-fitting works: in a randomised trial, adults who set up their own device with remote support did as well at six weeks as those fitted by an audiologist,[37] and a review of 15 studies in 774 adults found no difference on any outcome, at low certainty and mostly over a few weeks.[38] Both come from one group, and two authors report payments from the trial device's maker. For mild-to-moderate loss, an over-the-counter device is a reasonable first move.

See a clinician first if hearing dropped suddenly, is much worse in one ear, or comes with pain, discharge, ringing in one ear only, or vertigo.

Expect an adjustment period: most people need weeks to months before amplified sound stops feeling strange, and many quit in that window. A review of 25 controlled studies found the brain's adaptation in some users and some outcomes — 10 of 18 studies on speech recognition — with modest gains, and consistent daily wear was the one thing that predicted it.[39] Training apps reliably improve the trained task but carry over weakly to real conversation,[40] and pooled trials show nothing on working memory or attention.[41]

For protection, filtered earplugs are a sensible upgrade for a healthy adult at concerts, on motorcycles, with power tools and on factory floors, and the kind that is easier to keep wearing. They are passive: a precise channel and filter turn the whole spectrum down evenly, so music and speech stay clear.[42] Compare ratings on the same scale: Loop's Experience is 18 dB on the European SNR scale but 7 dB on the US NRR. Electronic protection, which clamps loud bangs, is mainly for shooting and long machinery work.

Sleep and diet: no ear vitamin

The cochlea has its own body clock, which governs its sensitivity to noise.[43] The popular next step, that sleep is when the cochlea clears damaging oxidants, has never been shown. In a US survey of 4,883 adults aged 20–69, hearing was best at about 8 hours of sleep and worse at both ends — but only in men and older adults, and in a single snapshot that cannot show sleep changing hearing.[44] Sleep well for the established reasons; see Sleep.

Diet signals are small and entirely observational. A review of 33 studies found inverse links between hearing loss and vitamin B2, β-carotene, fibre, fish and a few others, mostly in subgroups of otherwise null analyses; minerals and vitamins A, C and E showed nothing.[45] In Chinese adults averaging 79, a more varied plant-based diet tracked about 22% lower new hearing loss over about four years, though hearing was self-reported.[46] The pattern that fits is the same Mediterranean or MIND diet that serves the heart and brain.

Supplements have not earned a place. ACEMg, the heavily marketed vitamin-and-magnesium formula, rests on a retrospective chart review against historical controls by authors tied to the product,[47] and both of its randomised, placebo-controlled trials were null: a small study of 51 patients protecting leftover hearing during cochlear-implant surgery, which stopped early,[48] and one in normal-hearing adults exposed to loud music, where it did not prevent the temporary hearing loss and short-lived tinnitus was more common on the supplement.[49] No oral supplement, Audifort included, has been shown in a randomised trial to preserve human hearing.

Gene therapy: real, but for one rare deafness

On 23 April 2026 the US Food and Drug Administration gave accelerated approval to Otarmeni, the first gene therapy for hearing loss. It covers only severe-to-profound deafness caused by faulty copies of both OTOF genes, and only where the outer hair cells still work and the ear has no cochlear implant. Treatment needs ear surgery and a short course of steroids, and the label warns of complications from the procedure, including vertigo, tinnitus, infection, meningitis and facial-nerve paralysis.[50]

The approval rests on a single-arm trial with no control group, in which hearing improved in 80% of the 20 children who could be assessed, and continued approval depends on confirming that the effect lasts.[51] Every Otarmeni patient so far has been a child, though the approval covers adults too, and nobody 65 or older has been studied.[52]

OTOF accounts for only 2–8% of inherited non-syndromic deafness.[53] None of this reaches ordinary age-related hearing loss, which is years away from a fix. Don't wait for it.

Further reading

  • Livingston G et al. Dementia prevention, intervention, and care: 2024 report of the Lancet Standing Commission. Lancet 2024.[54]
  • Lin FR et al. Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial. Lancet 2023.[55]
  • Cribb L et al. Treating hearing loss with hearing aids for the prevention of cognitive decline and dementia (ASPREE target-trial emulation). Neurology 2026.[56]
  • Jia J et al. Hearing loss and its association with all-cause and cause-specific mortality: a meta-analysis of cohort studies. PLoS One 2025.[57]
  • Choi JS et al. Association between hearing aid use and mortality in adults with hearing loss in the USA: a mortality follow-up study of a cross-sectional cohort. Lancet Healthy Longev 2024 — a correction notice was published.[58]
  • Cederroth CR. Extended High-Frequency Hearing Loss, Not Cochlear Synaptopathy, Predicts Speech Recognition in a Population Cohort. medRxiv 2026 (preprint).[59]
  • Nisar M et al. Hearing Loss in Adults With Diabetes and Prediabetes: A Systematic Review and Meta-Analysis. Diabetes Metab Res Rev 2026.[60]
  • Deafness and hearing loss: safe listening. WHO, 2026. The Q&A that carries the weekly exposure table.[61]
  • CDC NIOSH science bulletin — chemicals and hearing loss. 2026.[62]
  • Ferguson MA et al. Hearing aids for mild to moderate hearing loss in adults. Cochrane Database Syst Rev 2026.[63]
  • Scheper V et al. Randomized placebo-controlled clinical trial investigating the effect of antioxidants and a vasodilator on overall safety and residual hearing preservation in cochlear implant patients. Trials 2020.[64]
  • FDA — first-ever gene therapy approval for genetic hearing loss (Otarmeni). 2026.[65]
  • Tsai Do BS et al. Clinical Practice Guideline: Age-Related Hearing Loss. Otolaryngol Head Neck Surg 2024.[66]
  • Levett BA et al. Hearing impairment and dementia: cause, catalyst or consequence? J Neurol 2025 — a correction was published in October 2025.[67]

— § —